Home/Filings/4/0001415889-24-016259
4//SEC Filing

Masoud Maher 4

Accession 0001415889-24-016259

CIK 0001287098other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 5:55 PM ET

Size

7.2 KB

Accession

0001415889-24-016259

Insider Transaction Report

Form 4
Period: 2024-06-07
Masoud Maher
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2024-06-10$4.90/sh+70,443$345,241100,000 total
  • Purchase

    Common Stock

    2024-06-07$4.87/sh+29,557$143,82429,557 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.84 to $4.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.77 to $5.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1
  • filerCIK 0001874571

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:55 PM ET
Size
7.2 KB